Neurogene Inc. is a clinical-stage company based in New York, NY, dedicated to developing life-changing genetic medicines for individuals and families affected by devastating neurological diseases. With a strong sense of purpose and a focus on innovation and scientific execution, Neurogene aims to harness the potential of gene therapy to revolutionize medical treatment.
Driven by a commitment to addressing the high unmet need for rare neurological diseases, Neurogene is building a gene therapy pipeline to bring hope and relief to those impacted by these conditions. Through their clinical programs and resources, Neurogene strives to advance the field of genetic medicine and improve the lives of patients and their families.
Generated from the website